Skin and skin structure infections: treatment with newer generation fluoroquinolones
نویسندگان
چکیده
منابع مشابه
Skin and skin structure infections: treatment with newer generation fluoroquinolones
Skin and skin structure infections (SSSI) are an emerging issue in healthcare. They are responsible for increasing heathcare utilization, both in hospitalizations and intravenous antibiotic use. SSSI are caused by an evolving variety of pathogens, including Gram-positive, Gram-negative, and anaerobic bacteria. In combination with mounting resistance patterns, this diverse range of bacteria mand...
متن کاملMoxifloxacin in the treatment of skin and skin structure infections
Moxifloxacin is a recent addition to the fluoroquinolone class, differing from ciprofloxacin and other older agents in having much better in vitro activity against Gram-positive aerobes while retaining potent activity against Gram-negative aerobes. It is also active against the pathogens of human and animal bite wounds and those species of atypical mycobacteria associated with dermatologic infe...
متن کاملSkin Infections and Travelers
Knowing the type of infections in different geographical regions may help to prevent the distribution of diseases. Vaccines, repellents, mosquito nets and clothes are recommended for preventing the increase of infectious diseases. There are different types of climate and geographical items around the world which determine the kind of skin infections. Travelers' skin diseases are recognized as s...
متن کاملVancomycin Combined With Clindamycin for the Treatment of Acute Bacterial Skin and Skin-Structure Infections.
BACKGROUND Acute bacterial skin and skin-structure infections (ABSSSIs) are common causes of hospital admissions. These infections are often caused by methicillin-resistant Staphylococcus aureus; therefore, vancomycin remains a commonly used therapy. The purpose of this study was to compare hospital length of stay (LOS) in patients treated with vancomycin monotherapy vs combination therapy with...
متن کاملOritavancin (Orbactiv): A New-Generation Lipoglycopeptide for the Treatment Of Acute Bacterial Skin and Skin Structure Infections.
Oritavancin (Orbactiv): a new-generation lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Therapeutics and Clinical Risk Management
سال: 2007
ISSN: 1176-6336
DOI: 10.2147/tcrm.2007.3.2.309